Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus DNA vaccine H5N1 - Fresh Tracks Therapeutics

Next Previous
Drug Profile

Influenza A virus DNA vaccine H5N1 - Fresh Tracks Therapeutics

Alternative Names: Bird flu DNA vaccine - Fresh Tracks Therapeutics; Influenza A (H5N1) DNA vaccine - Fresh Tracks Therapeutics; Pandemic influenza plasmid DNA vaccine H5N1 - Fresh Tracks Therapeutics; Vaxfectin-formulated plasmid DNA vaccine H5N1 - Fresh Tracks Therapeutics; VCL-IPM1; VCL-IPT1

Latest Information Update: 25 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vical
  • Developer Fresh Tracks Therapeutics
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Influenza A virus H5N1 subtype

Most Recent Events

  • 19 Sep 2023 Discontinued - Phase-I for Influenza A virus H5N1 subtype (Prevention) in USA (IM)
  • 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
  • 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top